Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Boehringer Ingelheim
Merck
Deloitte
Fish and Richardson

Generated: September 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,337,886

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,337,886
Title:Pellet formulation for the treatment of the intestinal tract
Abstract: An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a pharmaceutically tolerable salt or a derivative thereof.
Inventor(s): Otterbeck; Norbert (Uberlingen, DE)
Assignee: Dr. Falk Pharma GmbH (Freiburg, DE)
Application Number:12/236,157
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,337,886
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound; Process; Dosage form;

Drugs Protected by US Patent 8,337,886

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,337,886

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 32 903Jul 30, 1997

International Family Members for US Patent 8,337,886

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 241964 ➤ Sign Up
Canada 2297832 ➤ Sign Up
Germany 19732903 ➤ Sign Up
Germany 59808642 ➤ Sign Up
Denmark 0977557 ➤ Sign Up
European Patent Office 0977557 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
McKinsey
Colorcon
McKesson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.